Style Sampler

Layout Style

Patterns for Boxed Mode

Backgrounds for Boxed Mode

All fields are required.

Close Appointment form

High fitness levels reduce hypertension risk

High fitness levels reduce hypertension risk
High fitness levels reduce hypertension risk

The news follows a study led by Ludwig-Maximilians-Universität München in Germany (LMU) that demonstrated the vaccine’s protective effect in the lab and in mice.

Writing in the Journal of Virology, the researchers conclude that the vaccine – called MVA-MERS-S – meets important criteria for use in human trials.

Middle East respiratory syndrome (MERS) is a respiratory illness caused by the MERS coronavirus (MERS-CoV).

At first, infection causes flu-like symptoms, but they can progress to a severe respiratory illness that can be fatal.

There is currently no vaccine against MERS-CoV, which kills around 36% of people it infects.

MERS-CoV was first identified in 2012 when it emerged in Saudi Arabia. It has spread to other countries in the Arabian Peninsula and beyond, including the US and Germany – where the vaccine has been developed.

The present MERS outbreak in South Korea – where 166 confirmed cases and 12 deaths have been reported – is the largest so far recorded outside the Middle East.

There have been suggestions that mammals play a role in spreading MERS. For example, one study has suggested MERS may have started in bats, and another, that MERS could be carried by camels.